Fracture incidence in GH-deficient patients on complete hormone replacement including GH.

@article{Holmer2007FractureII,
  title={Fracture incidence in GH-deficient patients on complete hormone replacement including GH.},
  author={Helene Holmer and Johan Svensson and Lars Rylander and Gudmundur Johannsson and Thord Ros{\'e}n and B. -{\AA} Bengtsson and Marja Thor{\'e}n and Charlotte H{\"o}ybye and Marie Degerblad and Margareta Bramnert and Erik H{\"a}gg and Britt Ed{\'e}n Engstr{\"o}m and Bertil Ekman and K. G. Thorngren and Lars Hagmar and Eva Marie Therese Erfurth},
  journal={Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research},
  year={2007},
  volume={22 12},
  pages={1842-50}
}
UNLABELLED Fracture risk in GHD patients is not definitely established. Studying fracture incidence in 832 patients on GH therapy and 2581 matched population controls, we recorded a doubled fracture risk in CO GHD women, but a significantly lower fracture risk in AO GHD men. INTRODUCTION The objective of this study was to evaluate fracture incidence in… CONTINUE READING